[HTML][HTML] Pentraxin3 in chronic thromboembolic pulmonary hypertension: a new biomarker for screening from remitted pulmonary thromboembolism

A Naito, N Tanabe, T Jujo, A Shigeta, T Sugiura… - PLoS …, 2014 - journals.plos.org
Background Pentraxin3 (PTX3) is a protein, which has multifaceted effects on innate
immunity, angiogenesis, and vascular remodeling then could be a disease marker of acute …

[HTML][HTML] Human pentraxin 3 (PTX3) as a novel biomarker for the diagnosis of pulmonary arterial hypertension

Y Tamura, T Ono, M Kuwana, K Inoue, M Takei… - 2012 - journals.plos.org
Background Although inflammation is an important feature of pulmonary arterial
hypertension (PAH), the usefulness of local inflammatory markers as biomarkers for PAH is …

Circulating biomarkers in chronic thromboembolic pulmonary hypertension

M Zhang, Y Zhang, W Pang, Z Zhai… - Pulmonary …, 2019 - journals.sagepub.com
Chronic thromboembolic pulmonary hypertension (CTEPH) is a serious condition
characterized with chronic organized thrombi that obstruct the pulmonary vessels, leading to …

[HTML][HTML] Platelet, fibrinolytic and other coagulation abnormalities in newly-diagnosed patients with chronic thromboembolic pulmonary hypertension

E Vrigkou, A Tsantes, D Konstantonis, E Rapti… - Diagnostics, 2022 - mdpi.com
The pathophysiological background of chronic thromboembolic pulmonary hypertension
(CTEPH) has not been fully elucidated. Evidence suggests that abnormal platelet function …

[HTML][HTML] Role of NT-proBNP and 6MWD in chronic thromboembolic pulmonary hypertension

J Suntharalingam, K Goldsmith, M Toshner… - Respiratory …, 2007 - Elsevier
BACKGROUND: This study aims to evaluate the role of NT-proBNP and six minute walking
distance (6MWD) in the pre-and post-operative assessment of subjects undergoing …

Galectin-3, GDF-15, and sST2 for the assessment of disease severity and therapy response in patients suffering from inoperable chronic thromboembolic pulmonary …

SD Kriechbaum, CB Wiedenroth, K Peters, MA Barde… - Biomarkers, 2020 - Taylor & Francis
Purpose This study examined sST2, GDF-15, and galectin-3 as indicators of disease
severity and therapy response in chronic thromboembolic pulmonary hypertension …

[HTML][HTML] Fibrinogen plasma concentration is an independent marker of haemodynamic impairment in chronic thromboembolic pulmonary hypertension

JK Hennigs, HJ Baumann, N Lüneburg, G Quast… - Scientific reports, 2014 - nature.com
Fibrinogen has a crucial role in both inflammation and coagulation, two processes pivotal for
the pathogenesis of pulmonary hypertension. We therefore aimed to investigate whether …

[HTML][HTML] Keep minds opening for chronic thromboembolic pulmonary hypertension: More data, less clarity

YP Zhou, TY Lian, YJ Zhu - Journal of Thrombosis and Haemostasis, 2022 - jthjournal.org
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare sequelae of pulmonary
embolism (PE), resulting from persistent obstruction of pulmonary arteries with non-resolving …

Usefulness of thrombosis and inflammation biomarkers in chronic thromboembolic pulmonary hypertension—sampling plasma and surgical specimens

N Skoro-Sajer, C Gerges, M Gerges… - The Journal of Heart and …, 2018 - Elsevier
Background Chronic thromboembolic pulmonary hypertension (CTEPH) results from
persistent pulmonary vascular obstructions, presumably due to inflammatory thrombosis …

Pentraxin‐3 levels relate to the Wells score and prognosis in patients with acute pulmonary embolism

H Yang, J Zhang, Y Huan, Y Xu, R Guo - Disease Markers, 2019 - Wiley Online Library
Objective. To investigate the value of the PTX‐3 test in evaluating the prognosis of acute
pulmonary embolism (APE). Method. 117 APE patients were selected and divided into two …